Peptide Synthesis Market - Top Companies and Manufacturers

  • Report ID: 4800
  • Published Date: Jun 17, 2024
  • Report Format: PDF, PPT

Companies Dominating the Peptide Synthesis Landscape

top-features-companies
    • CordenPharma International
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Evonik
    • CSBio Company Inc.
    • Bachem Holding AG
    • Biotage
    • AAPP Tec
    • CEM Corporation
    • ProteoGenix
    • GenScript
    • Thermo Fisher Scientific Inc.

Browse Key Market Insights with Data Illustration:

In the News

  • Evonik has released a new peptide to boost cell-culture-based biopharmaceutical productivity. cWrex AC provides cells with a sufficient supply of soluble sources of this amino acid. The peptide offers a reliable source of L-cystine, which is an essential component for cell-culture-based biopharmaceuticals. This makes it possible for biopharmaceutical companies to increase their productivity by providing cells with a consistent and sufficient supply of amino acids.
     
  • CordenPharma International Company announced a collaboration with PeptiSystems, a Swedish manufacturer of flow-through column-based instruments for the research and production of peptide and oligonucleotide therapeutics.

Author Credits:  Rajrani Baghel


  • Report ID: 4800
  • Published Date: Jun 17, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of peptide synthesis is evaluated at USD 683.91 Million.

The peptide synthesis market size was over USD 606.73 Million in 2023 and is projected to exceed USD 1.46 Billion by the end of 2036, witnessing over 7.1% CAGR during the forecast period i.e., between 2024-2036. Growing expenditure by the pharmaceutical industry on R&D along with growth in drug approvals and high usage in COVID-19 treatment are some of the major factors anticipated to drive the growth of the market.

North America industry is slated to dominate reveue share by 2036, backed by government and academic institutions increasing efforts to create innovative peptide-based medicinal pharmaceuticals in the region.

CordenPharma International, Evonik, CSBio Company Inc., Bachem Holding, AGBiotage, AAPP Tec, CEM Corporation, ProteoGenix, GenScript, Thermo Fisher Scientific Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying